期刊文献+

《中国肺动脉高压诊断与治疗指南(2021版)》解读——儿童肺动脉高压 被引量:1

Interpretation of Guidelines to the diagnosis and treatment of pulmonary hypertension in China(2021):pediatric pulmonary hypertension
原文传递
导出
摘要 儿童肺动脉高压(PH)定义为出生3个月后在海平面水平静息状态下平均肺动脉压≥25 mmHg。《中国肺动脉高压诊断与治疗指南(2021版)》(简称“指南”)对儿童PH的诊断评估及治疗进行总结,强调了儿童PH与成人的区别,文章旨在结合临床实践对指南中儿童PH部分进行解读。 Pediatric pulmonary hypertension(PH)is defined as mean pulmonary arterial pressure(mPAP)≥25 mmHg at sea level in the rest at 3 months of birth.Diagnostic assessment and treatment of pediatric PH were summarized in Guidelines to the diagnosis and treatment of pulmonary hypertension in China(2021).The difference between child PH and adult PH was emphasized.Based on clinical practice,the article will give an interpretation of diagnosis and treatment of pediatric PH in this guidelines.
作者 张明杰 徐卓明 ZHANG Ming-jie;XU Zhuo-ming(Department of Thoracic and Cardiovascular Surgery,Shanghai Children’s Medical Center,School of Medicine,Shanghai Jiaotong University,Shanghai 200127,China)
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2022年第3期206-209,共4页 Chinese Journal of Practical Internal Medicine
基金 国家自然科学基金(81771934) 上海交通大学交大之星医工交叉研究基金(YG2019ZDA03)。
关键词 儿童肺动脉高压 右心导管检查 急性肺血管扩张试验 pediatric pulmonary hypertension right heart catheterization acute pulmonary vasodilator testing
  • 相关文献

参考文献5

二级参考文献26

  • 1Hong-fang JIN,Jun-bao DU,Xiao-hui LI,Yan-fei WANG,Yin-fang LIANG,Chao-shu TANG.Interaction between hydrogen sulfide/cystathionine γ-lyase and carbon monoxide/heme oxygenase pathways in aortic smooth muscle cells[J].Acta Pharmacologica Sinica,2006,27(12):1561-1566. 被引量:8
  • 2Ma M, Gauvreau K, Allan CK, et al. Causes of death after congenital heart surgery. Ann Thorac Surg, 2007, 83 : 1438-1445. 被引量:1
  • 3Hawort SG. The management of pulmonary hypertension in children. Arch Dis Child, 2008, 93:620-625. 被引量:1
  • 4Hsu HH, Chen JS, Chen RJ, et al. Long-term outcome and effects of oral bosentan therapy in Taiwan Residents patients with advanced idiopathic pulmonary arterial hypertension. Respir Med, 2007, 101 : 1556-1562. 被引量:1
  • 5Lammers AE, Hislop AA, Flynn Y, et al. The 6-minute walk test: normal values for children of 4-11 years of age. Arch Dis Child, 2008, 93:464-468. 被引量:1
  • 6Keogh AM, McNeil KD, Wlodarczyk J, et al. Quality of life in pulmonary arterial hypertension: improvement and maintenance with bosentan. J Heart Lung Transplant, 2007, 26 : 181-187. 被引量:1
  • 7Galie N, Beghetti M, Gatzoulis MA, et al. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation, 2006, 114 : 48-54. 被引量:1
  • 8Barst R, Ivy D, Dingemanse J, et al. Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin Pharmacol Ther, 2003, 73:372-382. 被引量:1
  • 9Rosenzweig EB, Ivy DD, Widlitz A, et al. Effects of long-term bosentan in children with pulmonary arterial hypertension. J Am Coll Cardiol, 2005, 46:697-704. 被引量:1
  • 10Haworth SG, Hislop AA. Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006. Heart, 2009, 95:312-317. 被引量:1

共引文献63

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部